Thomas J Haronian, MD | |
593 Eddy St, Claverick 2, Providence, RI 02903-4923 | |
(401) 854-2504 | |
(401) 854-2519 |
Full Name | Thomas J Haronian |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 593 Eddy St, Providence, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609896554 | NPI | - | NPPES |
04/15/2009 | Other | RI | UNITED HEALTHCARE |
930039834 | Other | RI | RAILROAD MEDICARE |
01/27/2009 | Other | MA | TUFTS HEALTH PLAN |
12/14/2006 | Other | RI | NHPRI |
1609896554 | Other | RI | NPI |
9006744 | Medicaid | RI | |
3192334 | Medicaid | MA | |
939025129 | Other | RI | RI MEDICARE GROUP NUMBER |
203492 | Other | RI | BCBSRI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD08472 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Thomas J Haronian, MD Po Box 9484, Providence, RI 02940-9484 Ph: (401) 854-2500 | Thomas J Haronian, MD 593 Eddy St, Claverick 2, Providence, RI 02903-4923 Ph: (401) 854-2504 |
News Archive
A new study published in November 2020 on the preprint server medRxiv* indicates that the chances of symptomatic infection are indeed much lower among the population with antibodies to the virus.
Breast cancer patients who have a strong social support system in the first year after diagnosis are less likely to die or have a recurrence of cancer, according to new research from Vanderbilt-Ingram Cancer Center and the Shanghai Institute of Preventive Medicine.
Distinct from virus transmission patterns identified elsewhere, analysis of SARS-CoV-2 genomes from a small number of California-based patients suggests the virus arrived in northern California through a complex series of introductions, not only from state to state but also from international travel.
Pfizer Inc. announced today that the U.S. Food and Drug Administration has granted approval of the use of a Prefilled Dual-Chamber Syringe for administration of XYNTHA® Antihemophilic Factor (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant factor VIII product indicated for both the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.
The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research contract from the National Institutes of Health to develop an automated platform to quantify the latent HIV reservoir.
› Verified 8 days ago
Dr. Robert A Partridge, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-519-1604 Fax: 401-272-0538 | |
Dr. Gregory R Lockhart, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Claverick 2, Providence, RI 02903 Phone: 401-444-4000 Fax: 401-427-7795 | |
Ian M Jacobson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 825 Chalkstone Ave, Providence, RI 02908 Phone: 330-493-4443 | |
Dr. Daniel Shanin, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St., Claverick 2, Providence, RI 02903 Phone: 401-444-4000 | |
Carli Renske Reisdorf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6680 | |
Dr. Oriane Diana Longerstaey, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Providence, RI 02906 Phone: 704-355-3181 | |
Rachel Smith Shain, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-6489 Fax: 401-444-6662 |